CAR-specific monoclonal FMC63 antibodies for CD19 CAR expression evaluation

In CAR-T therapy, CD19 is now the most extensively used target. It has been confirmed to be effective and safe for the treatment of CLL, B-ALL and B cell lymphoma. FMC63, an IgG2a mouse monoclonal antibody, targets CD19.

To date, a majority of the reported CART19 trials include the anti-CD19 scFv extracted from FMC63, such as both the FDA-approved CARs Kymriah and Yescarta.

Although the therapeutic results for CD19-specific CAR-T cells have been impressive, the quality control at the time of therapy manufacture has been an area where more progress is still needed. The high-affinity CD19 proteins from ACROBiosystems exhibit the potential to effectively detect the anti-CD19 CAR expression on the surface of transduced T cells. These proteins have been recognized widely for their superior sensitivity and specificity.

The ACROBiosystems high-affinity CD19 proteins have found extensive use for the quality control release testing and pharmacokinetic (PK) analysis of anti-CD19 CAR-T cells in clinical trials.

With positive feedback related to its high-affinity CD19 proteins available in the market, ACROBiosystems has now created an anti-idiotypic antibody against FMC63 scFv, known as Monoclonal Anti-FMC63 scFv Antibody. This antibody has the potential to specifically recognize the antigen-recognition domain of FMC63 derived anti-CD19 CARs with superior sensitivity and specificity.

The anti-FMC63 scFv monoclonal antibody’s performance was verified in house through flow cytometry (FCM), and it was found to be ideal for the detection of FMC63-derived anti-CD19 CARs in clinical trials.

Product list

Table 1. Source: ACROBiosystems

Molecule Cat. No. Source Product Description
FMC63 FM3-Y45 Hybridoma Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45)
FM3-Y45P1 HEK293 Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (HEK293)
FM3-FY45 Hybridoma FITC-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45)New
FM3-BY45 Hybridoma Biotinylated Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45)New
FM3-BY54 HEK293 Biotinylated Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1, Avitag™ (Y45)
FM3-HPY53 HEK293 PE-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Site-specific conjugation)
FM3-S93   Rabbit Anti-Mouse FMC63 scFv Polyclonal Antibody (recommended for ADA assay) (MALS verified)

 

Product features

No background staining when detecting FMC63 derived Anti-CD19 CARs in clinical trials

Detection of anti-CD19 (FMC63) CAR expression

2e5 of FMC63 scFv-based anti-CD19 CAR-293 cells were stained with 100 µL of the working solution of Monoclonal AntiFMC63 scFv Antibody, Mouse IgG1 (Cat. No. FM3-Y45) and isotype control respectively, washed and then followed by PE anti-mouse IgG1 Antibody and analyzed with flow cytometry (QC tested).

2e5 of FMC63 scFv-based anti-CD19 CAR-293 cells were stained with 100 µL of the working solution of Monoclonal AntiFMC63 scFv Antibody, Mouse IgG1 (Cat. No. FM3-Y45) and isotype control respectively, washed and then followed by PE anti-mouse IgG1 Antibody and analyzed with flow cytometry (QC tested). Image Credit: ACROBiosystems

Assessment of non-specific binding to 293 cells

Non-specific binding of Monoclonal Anti-FMC63 scFv Antibody (Cat. No. FM3-Y45) to non-transfected 293 cells was determined by flow cytometry. The data showed that Anti-FMC63 scFv Antibody didn’t bind to non-transfected 293 cells.

Non-specific binding of Monoclonal Anti-FMC63 scFv Antibody (Cat. No. FM3-Y45) to non-transfected 293 cells was determined by flow cytometry. The data showed that Anti-FMC63 scFv Antibody didn’t bind to non-transfected 293 cells. Image Credit: ACROBiosystems

Assessment of non-specific binding to PBMCs

Non-specific binding of Monoclonal Anti-FMC63 scFv Antibody (Cat. No. FM3-Y45) to non-transfected human PBMCs was determined by flow cytometry. The data showed that Anti-FMC63 scFv Antibody didn’t bind to non-transfected human PBMCs.

Non-specific binding of Monoclonal Anti-FMC63 scFv Antibody (Cat. No. FM3-Y45) to non-transfected human PBMCs was determined by flow cytometry. The data showed that Anti-FMC63 scFv Antibody didn’t bind to non-transfected human PBMCs. Image Credit: ACROBiosystems

Specifically recognize the antigen-binding site of FMC63 derived CARs with high affinity

Binding activity and specificity measured by ELISA

Immobilized FMC63 scFv, His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Clone Y45) with a linear range of 1-19 ng/mL. Anti-DNP antibody, mouse IgG1 (Cat. No. DNP-M1) was used as an isotype control (QC tested).

Immobilized FMC63 scFv, His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Clone Y45) with a linear range of 1-19 ng/mL. Anti-DNP antibody, mouse IgG1 (Cat. No. DNP-M1) was used as an isotype control (QC tested). Image Credit: ACROBiosystems

Neutralizing activity measured by ELISA

ELISA analysis shows that the binding of Human CD19, Fc Tag (Cat. No. CD9-H5251) to FMC63 scFv, His Tag was inhibited by increasing concentration of Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Clone Y45). The concentration of Human CD19, Fc Tag used is 5 μg/mL (100 μL/well). The IC50 is 0.084 μg/mL (Routinely tested).

ELISA analysis shows that the binding of Human CD19, Fc Tag (Cat. No. CD9-H5251) to FMC63 scFv, His Tag was inhibited by increasing concentration of Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Clone Y45). The concentration of Human CD19, Fc Tag used is 5 μg/mL (100 μL/well). The IC50 is 0.084 μg/mL (Routinely tested). Image Credit: ACROBiosystems

High affinity determined by SPR

Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Cat. No. FM3-Y45) captured on CM5 chip via anti-mouse antibodies surface can bind FMC63 scFv with an affinity constant of 1.08 nM as determined in an SPR assay.

Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Cat. No. FM3-Y45) captured on CM5 chip via anti-mouse antibodies surface can bind FMC63 scFv with an affinity constant of 1.08 nM as determined in an SPR assay. Image Credit: ACROBiosystems

Product list of high affinity CD19 proteins

Table 2. Source: ACROBiosystems

Molecule Cat. No. Source Product Description Structure
CD19 CD9-HP2H3 HEK293 PE-Labeled Human CD19 (20-291) Protein, His
Tag (Site-specific conjugation)Hot
CD9-H5251 HEK293 Human CD19 (20-291) Protein, Fc Tag, low endotoxin (Super affinity, MALS verified) DMF FiledHot
CD9-H52H2 HEK293 Human CD19 (20-291) Protein, His Tag DMF FiledHot
CD9-H5259 HEK293 Human CD19 (20-291) Protein, Fc Tag, low endotoxin
CD9-H5250 HEK293 Human CD19 (20-291) Protein, Llama IgG2b Fc Tag, low endotoxin
CD9-H5258 HEK293 Human CD19 (20-291) Protein, Mouse IgG2a Fc Tag
CD9-HF2H2 HEK293 FITC-Labeled Human CD19 (20-291) Protein, His Tag DMF FiledHot
CD9-HF251 HEK293 FITC-Labeled Human CD19 (20-291) Protein, Fc Tag DMF FiledHot
CD9-HF2H3 HEK293 FITC-Labeled Human CD19 (20-291) Protein, His Tag Star Staining
CD9-H8259 HEK293 Biotinylated Human CD19, Fc Tag, ultra
sensitivity (primary amine labeling) DMF Filed
CD9-H82F7 HEK293 Biotinylated Human CD19 (20-291) Protein, Fc, Avitag™Hot
CD9-H82E9 HEK293 Biotinylated Human CD19 (20-291) Protein, His, Avitag™ (SPR verified)Hot
MBS-K005   Human CD19-coupled Magnetic Beads  
CD9-C5251 HEK293 Cynomolgus / Rhesus macaque CD19 (20-292) Protein, Fc Tag
CD9-C5221 HEK293 Cynomolgus / Rhesus macaque CD19 (20-292) Protein, His Tag

Other Equipment by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.